We're moving to rndsystems.com. Come with us!

After August 17, 2026, Novus Biologicals products and services will no longer be available on this website; you will access all products and services on rndsystems.com. Create your R&D Systems online account today.

ILT4/CD85d/LILRB2 Products

Antibodies
ILT4/CD85d/LILRB2 Antibody (2 ...
ILT4/CD85d/LILRB2 Antibody (287219...
MAB2078
Species: Hu
Applications: WB, Flow, B/N, CyTOF-ready
Host: Mouse Monoclonal
ELISA Kits
Human ILT4/CD85d/LILRB2 ELISA ...
Human ILT4/CD85d/LILRB2 ELISA Kit ...
NBP3-49817
Species: Hu
Applications: ELISA
Lysates
ILT4/CD85d/LILRB2 Overexpress ...
ILT4/CD85d/LILRB2 Overexpression L...
NBL1-12527
Species: Hu
Applications: WB
ILT4/CD85d/LILRB2 Overexpress ...
ILT4/CD85d/LILRB2 Overexpression L...
NBL1-12528
Species: Hu
Applications: WB
Proteins
Recombinant Human LILRB2/CD85 ...
Recombinant Human LILRB2/CD85d/ILT...
8429-T4
Species: Hu
Applications: Bioactivity
Formulation Catalog # Availability Price  
Recombinant Human LILRB2/CD85 ...
Recombinant Human LILRB2/CD85d/ILT...
2078-T4
Species: Hu
Applications: Bioactivity
Formulation Catalog # Availability Price  
Recombinant Human LILRB2/CD85 ...
Recombinant Human LILRB2/CD85d/ILT...
AVI2078
Species: Hu
Applications: Bioactivity
Conjugate Catalog # Availability Size Price
Formulation Catalog # Availability Price  

Description

The immunoglobulin-like transcript (ILT) comprise a family of activating and inhibitory type immunoreceptors whose genes are located in the same locus that encodes killer cell Ig-like receptors (KIR) (1-3). ILT4, also known as LIR-2 and LILRB2, is a type I transmembrane protein expressed primarily on monocytes and dendritic cells (DC) (4). Human ILT4 is produced as a 598 amino acid (aa) precursor including a 21 aa signal sequence, a 440 aa extracellular domain (ECD), a 21 aa transmembrane segment, and a 116 aa cytoplasmic domain. The ECD contains four Ig-like domains, and the cytoplasmic domain contains three immunoreceptor tyrosine-based inhibitory motifs (ITIM) (5). The ECD of human ILT4 shares 76% aa identity with chimpanzee ILT4 and 74%, 81%, 33%, 52%, 77%, 61%, and 64 % aa identity with human ILT1, 2, 3, 5, 6, 7, and 8, respectively. ILT4 binds to classical MHC I proteins as well as the non-classical HLA-G1 and HLA-F molecules (5-9). It competes with CD8 alpha for MHC I binding but does not compete with KIR2DL1 (7). Ligation of ILT4 induces Tyr phosphorylation within its cytoplasmic ITIMs, a requirement for association with SHP-1 (4, 6). Activation of ILT4 inhibits signaling through Fc gamma RI (4) and Fc epsilon RI (6) and causes DC to become tolerogenic by down‑regulation of co‑stimulatory molecules (10, 11). ILT4 mediates tolerogenic DC‑induced CD4+ T cell energy in vitro and in vivo (10-12).

Bioinformatics

Uniprot
Product By Gene ID 10288
Alternate Names
  • CD85 antigen-like family member D
  • CD85d antigen
  • CD85d
  • Ig-like transcript 4
  • ILT4
  • ILT-4
  • ILT4CD85d
  • Immunoglobulin-like transcript 4
  • Leukocyte immunoglobulin-like receptor 2
  • leukocyte immunoglobulin-like receptor subfamily B member 2 soluble isoform
  • leukocyte immunoglobulin-like receptor subfamily B member 2
  • leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains)
  • LILRB2
  • LIR2
  • LIR2CD85D
  • LIR-2subfamily A (with TM domain), member 6
  • member 2
  • MIR10
  • MIR10LILRA6
  • Monocyte/macrophage immunoglobulin-like receptor 10